In this research presentation, Dr. Robert J. Snyder reports on the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm and microbial loads in...
In this research presentation, Dr. Robert J. Snyder reports on the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm and microbial loads in...
In this interview, Dr. Robert J. Snyder provides insight into future plans to further the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm...
In this interview, Dr. Robert J. Snyder provides insight into future plans to further the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm...
This video features an interview with members of the ECRI Institute-Penn Medicine Evidence-Based Practice Center (ECRI) and the Agency for Healthcare Research and Quality regarding a systematic review of skin substitutes conducted by the ECRI...
This video features an interview with members of the ECRI Institute-Penn Medicine Evidence-Based Practice Center (ECRI) and the Agency for Healthcare Research and Quality regarding a systematic review of skin substitutes conducted by the ECRI...
David Armstrong, PhD, DPM, expands on a recent study looking at the cost effectiveness of DHACM in treating lower extremity diabetic ulcers, and how the results might translate in the clinic and for payers.
David Armstrong, PhD, DPM, expands on a recent study looking at the cost effectiveness of DHACM in treating lower extremity diabetic ulcers, and how the results might translate in the clinic and for payers.
David Armstrong, PhD, DPM, discusses how DHACM treatment led to reductions in amputations, hospital readmissions, and cost for patients with diabetic ulcers.
David Armstrong, PhD, DPM, discusses how DHACM treatment led to reductions in amputations, hospital readmissions, and cost for patients with diabetic ulcers.
Martha R. Kelso, RN, HBOT, touches on the extent of the evidence supporting a study on the cost-effectiveness of dHACM allografts in lower extremity diabetic ulcers.
Martha R. Kelso, RN, HBOT, touches on the extent of the evidence supporting a study on the cost-effectiveness of dHACM allografts in lower extremity diabetic ulcers.
Martha R. Kelso, RN, HBOT, discusses how a recent study on the efficacy and cost-effectiveness of dHACM allografts is important for conveying to payers how important it is to cover advanced treatment modalities.
Martha R. Kelso, RN, HBOT, discusses how a recent study on the efficacy and cost-effectiveness of dHACM allografts is important for conveying to payers how important it is to cover advanced treatment modalities.
Join us for an engaging webinar that will enhance your surgical skills and knowledge on the impact of CAMPs. This session will dive into the innovative use of Cellular, Acellular, and Matrix-Like Products (CAMPs) in managing complex surgical tissue reconstructions and challenging wounds...
Presented by: Luis G. Fernández, MD, KHS, KCOEG, FACS, FASAS, FCCP, FCCM, FICS; Paul J. Kim, DPM, MS, FACFAS; and Saeed A. Chowdhry, MD, FACS.
It is known in the literature about the clinical and economic benefits of instillation therapy, ranging from reductions in hospital stays to fe...